~~<i id='42100CA105'><strike id='42100CA105'><tt id='42100CA105'><pre id='42100CA105'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

hotspot

Wikipedia

author：Wikipedia 2025-09-27 12:48:24 - browse：4341

The FDA building -- First Opinion coverage from STAT — Adobe

WASHINGTON — The Food and Drug Administration’s top cancer drug regulator doesn’t always ask for permission before taking on big initiatives.

Richard Pazdur, director of the FDA Oncology Center of Excellence, hates bureaucracy. It stifles his ideas for getting treatments to cancer patients faster — of which there are many.

To cut through that bureaucracy, Pazdur has a trick: “Don’t tell anybody,” he said to laughter at a meeting of the advocacy group Friends of Cancer Research Tuesday.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： What does generative AI mean for health care? We asked experts
Next article： California wildfire smoke linked to 52,000 early deaths, study says

Wikipedia

hotspot

leisure time

explore

AdobeVirtualcarecompanyTeladochasanewchiefexecutiveofficerfollowingtheabruptdepartureofitslongtimele

WSS

Wellcome Trust names Røttingen as its new CEO

Lilly's Alzheimer's drug donanemab backed by FDA advisers

5 takeaways from STAT's examination of Zynex Medical

5 takeaways from STAT's examination of Zynex Medical

Cigna wins case to block Amy Bricker's move to CVS

How doctors and nurses shape Google's AI

hotspot

Wikipedia

Wikipedia

How to save PrEP access — and even expand it

Bernie Sanders bashes nonprofit hospitals over their tax breaks

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

European regulators recommend Amylyx's ALS drug be rejected

Hepatitis C has a cure — but many Americans still lack access to it

California wildfire smoke linked to 52,000 early deaths, study says

As demand for Covid shots wanes, Moderna seeks its next success

Curing rare childhood diseases will falter unless Congress steps up

Walensky prepares to leave CDC — and Congress — behind

Pharma companies must ensure equitable access to obesity drugs

hotspot

Akero's treatment for NASH falls short in cirrhosis study

New report analyzes digital physical therapy solutions' effectiveness

What the Wegovy shortage looks like for doctors — and for patients

Study: Why relieving medical debt did not improve financial outcomes

How faith leaders like me can help address America's obesity epidemic

Pharma companies must ensure equitable access to obesity drugs

hotspot

hotspot

leisure time

explore